A review in Nature Reviews Materials explores the potential of edible materials in creating robotic foods and edible robots, highlighting their therapeutic and environmental benefits, while addressing current research challenges.
Novel BTK Inhibitor for Chronic Hives Wins in Phase III Trial
ANAHEIM, Calif. — Treatment with remibrutinib, an investigational Bruton’s tyrosine kinase (BTK) inhibitor, led to fast improvement in symptom control for patients with chronic spontaneous